Imeik Technology Development Co.,Ltd.

SZSE:300896 Stock Report

Market Cap: CN¥50.2b

Imeik Technology DevelopmentLtd Past Earnings Performance

Past criteria checks 5/6

Imeik Technology DevelopmentLtd has been growing earnings at an average annual rate of 38.5%, while the Biotechs industry saw earnings growing at 5.4% annually. Revenues have been growing at an average rate of 36.1% per year. Imeik Technology DevelopmentLtd's return on equity is 28.1%, and it has net margins of 64.7%.

Key information

38.5%

Earnings growth rate

34.9%

EPS growth rate

Biotechs Industry Growth11.3%
Revenue growth rate36.1%
Return on equity28.1%
Net Margin64.7%
Next Earnings Update22 Aug 2024

Recent past performance updates

Recent updates

Are Investors Undervaluing Imeik Technology Development Co.,Ltd. (SZSE:300896) By 47%?

Jul 02
Are Investors Undervaluing Imeik Technology Development Co.,Ltd. (SZSE:300896) By 47%?

Why Investors Shouldn't Be Surprised By Imeik Technology Development Co.,Ltd.'s (SZSE:300896) P/E

Feb 29
Why Investors Shouldn't Be Surprised By Imeik Technology Development Co.,Ltd.'s (SZSE:300896) P/E

Revenue & Expenses Breakdown

How Imeik Technology DevelopmentLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:300896 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 243,0471,972390264
31 Dec 232,8691,858409250
30 Sep 232,6201,695422217
30 Jun 232,5131,642398213
31 Mar 232,1381,404332188
01 Jan 231,9391,264291173
30 Sep 221,9141,236276156
30 Jun 221,6991,118258123
31 Mar 221,6191,061258108
01 Jan 221,448958221102
30 Sep 211,26885818990
30 Jun 211,10171816485
31 Mar 2188956713478
31 Dec 2070944011462
30 Sep 2062737611351
31 Dec 1955830612649
31 Dec 1832112310734
31 Dec 17222826828
31 Dec 1614153600
31 Dec 1511218740
31 Dec 147528360

Quality Earnings: 300896 has high quality earnings.

Growing Profit Margin: 300896's current net profit margins (64.7%) are lower than last year (65.6%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 300896's earnings have grown significantly by 38.5% per year over the past 5 years.

Accelerating Growth: 300896's earnings growth over the past year (40.5%) exceeds its 5-year average (38.5% per year).

Earnings vs Industry: 300896 earnings growth over the past year (40.5%) exceeded the Biotechs industry -7.5%.


Return on Equity

High ROE: 300896's Return on Equity (28.1%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.